Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP-9632P Pharmacodynamics and Safety in Levodopa-Induced Dyskinesia in Parkinson's Disease
jRCT2031220051Completed
- Sponsor
- Sumitomo Pharma
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Parkinson's disease (PD) and levodopa-induced dyskinesia (LID) comparing DSP-9632P transdermal with Placebo transdermal (2 arms). Started Jun 2022; status: completed.
02
Drugs
DSP-9632P
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on jRCT2031220051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220051.